or
forgot password
  • cancer clinical trials in detroit, MI

  • Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Regional Transitional Cell Cancer of the Renal Pelvis and Ureter, Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer, Urethral Cancer Associated With Invasive Bladder Cancer
    S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Lung Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Leukemia, Myelodysplastic Syndromes
    Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Breast Cancer, Cognitive/Functional Effects, Lung Cancer, Metastatic Cancer, Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
    Henry Ford Hospital
    Detroit, Michigan 48202
    Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Breast Cancer
    AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
    Henry Ford Health Systems
    Detroit, Michigan 48202
    Glioblastoma Multiforme
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    Karmanos Cancer Institute/Children's Hospital of Michigan
    Detroit, Michigan 48201
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Henry Ford Hospital

    Trial Locations
    Henry Ford Hospital
    St. John's Hospital and Medical Center
    Mycoses, Candidiasis, Invasive, Candidemia
    Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
    Henry Ford Hospital
    Detroit, Michigan 48202
    Glioblastoma Multiforme, Gliosarcoma
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Bladder Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Lung Cancer
    Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
    Wayne State University
    Detroit, Michigan 48202
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Brain and Central Nervous System Tumors
    S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Leukemia
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Neuroblastoma
    Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Veterans Affairs Medical Center - Detroit
    Prostate Cancer
    Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
    Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (4)
    Detroit, Michigan 48201
    Advanced Neuroendocrine Tumors
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Multiple Myeloma
    Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Sinai-Grace Hospital
    Kidney Cancer, Lung Cancer, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
    Sinai-Grace Hospital
    Detroit, Michigan 48235
    Multiple Myeloma and Plasma Cell Neoplasm
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Lung Cancer, Radiation Toxicity
    Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery
    Wayne State University
    Detroit, Michigan 48202
    Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer
    CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
    Henry Ford Health System
    Detroit, Michigan 48202
    Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Henry Ford Hospital
    Detroit, Michigan 48202
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer